The University of Queensland is seeking participants in a trial to investigate the effects of sprouted broccoli capsules on Type 2 diabetic patients.
UQ School of Human Movement Studies PhD student Christine Houghton said the broccoli-derived sulforaphane compound has many health benefits.
“The health benefits are a response to activating a range of antioxidant and other protective genes,” she said. “Activating these genes has been shown to reduce the degree of oxidative stress, a contributor to a number of diseases, including Type 2 diabetes.”
Ms Houghton is working with other UQ researchers to conduct clinical trials designed to develop a new intervention for the disease.
“Other studies have shown that sulforaphane from broccoli sprout powder might reduce the signs and symptoms of Type 2 diabetes. However, this will be the first time a characterised broccoli capsule will be used in a clinical trial,” she said.
Type 2 diabetes sufferers between 18 and 45 are invited to participate in the study.
